Case Series: Cancer-Related Facial Pain Treated with Stellate Ganglion Block
dc.contributor.author | Darabad, Raheleh Rahimi | |
dc.contributor.author | Kalangara, Jerry P. | |
dc.contributor.author | Woodbury, Anna | |
dc.contributor.department | Anesthesia, School of Medicine | en_US |
dc.date.accessioned | 2023-02-03T16:44:49Z | |
dc.date.available | 2023-02-03T16:44:49Z | |
dc.date.issued | 2020-12-02 | |
dc.description.abstract | Stellate ganglion block (SGB) is believed to modify the pathologic sympathetic pain response and has been commonly used to treat complex regional pain syndrome. We report successful treatment of cancer-related facial pain with SGB in three patients, suggesting a possible sympathetic pain-related mechanism. All patients exhibited clinically significant improvement of pain 12 weeks following the procedure. SGB should be considered a palliative pain treatment option in cancer-related facial pain. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Darabad RR, Kalangara JP, Woodbury A. Case Series: Cancer-Related Facial Pain Treated with Stellate Ganglion Block. Palliat Med Rep. 2020;1(1):290-295. Published 2020 Dec 2. doi:10.1089/pmr.2020.0042 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/31141 | |
dc.language.iso | en_US | en_US |
dc.publisher | Mary Ann Liebert, Inc. | en_US |
dc.relation.isversionof | 10.1089/pmr.2020.0042 | en_US |
dc.relation.journal | Palliative Medicine Reports | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | Cancer | en_US |
dc.subject | Orofacial pain | en_US |
dc.subject | Stellate ganglion block | en_US |
dc.subject | Sympathetic ganglia | en_US |
dc.title | Case Series: Cancer-Related Facial Pain Treated with Stellate Ganglion Block | en_US |
dc.type | Article | en_US |